This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Davies, A. N Articles by Sharma, K. Search for Related Content PubMed PubMed Citation Articles by Davies, A. N Articles by Sharma, K. Social Bookmarking                         What's this?

A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer

Palliative Medicine, St Christopher's Hospice, London

Charles Daniels

Rosamund Pugh

Palliative Medicine, Forest Holme, Poole

Kiran Sharma

Palliative Medicine, St Catherine's Hospice, Crawley

This was a crossover study comparing a mucin-based artificial saliva (Saliva Orthana^TM) and pilocarpine hydrochloride (Salagen^TM) in the management of xerostomia in patients with advanced cancer. The pilocarpine was found to be more effective than the artificial saliva in terms of mean change in visual analogue scale scores for xerostomia (P = 0.003). Furthermore, more patients reported that it had helped their xerostomia, and more patients wanted to continue with it after the study. However, the pilocarpine was found to be associated with more side-effects than the artificial saliva (P < 0.001). These side-effects were usually reported as being mild. Of the patients who used both treatments, 50% preferred the artificial saliva, and 50% preferred the pilocarpine. The commonest reason for preferring the artificial saliva was the fact that it was a spray, rather than a tablet.

Key Words: saliva, artificial • pilocarpine • xerostomia • neoplasms • palliative care

Palliative Medicine, Vol. 12, No. 2, 105-111 (1998)
DOI: 10.1191/026921698670435903


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Nikles, G. Mitchell, J. Walters, J. Hardy, P. Good, D. Rowett, T. Shelby-James, and D. Currow Prioritising drugs for single patient (n-of-1) trials in palliative care Palliative Medicine, October 1, 2009; 23(7): 623 - 634. [Abstract] [PDF]

				S Mercadante, L Calderone, P Villari, R Serretta, M Sapio, A Casuccio, and F Fulfaro The use of pilocarpine in opioid-induced xerostomia Palliative Medicine, September 1, 2000; 14(6): 529 - 531. [PDF]

				A. N Davies A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer Palliative Medicine, April 1, 2000; 14(3): 197 - 203. [Abstract] [PDF]

				P. Stone and R. A'Hern Artificial saliva versus pilocarpine for xerostomia Palliative Medicine, January 1, 1999; 13(1): 81 - 82. [PDF]

				A. Davies and P. Williams Authors' reply and correction Palliative Medicine, January 1, 1999; 13(1): 82 - 83. [PDF]

				C. Regnard, S. Allport, and L. Stephenson Mouth care and skin care in palliative medicine BMJ, October 10, 1998; 317(7164): 1013 - 1013. [Full Text]